Litcius/Paper detail

Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: Systematic review and case

M. Harrison Snyder, Leonel Ampie, Joseph D. DiDomenico, Ashok R. Asthagiri

2021Journal of Clinical Neuroscience20 citationsDOI

Topics & Concepts

MedicineNeurofibromatosis type 2BevacizumabEpendymomaNeurofibromatosisSurgeryRadiologyChemotherapyNeurofibromatosis and Schwannoma CasesVascular Malformations Diagnosis and TreatmentMeningioma and schwannoma management
Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: Systematic review and case | Litcius